| 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with … MS Aapro, J Bohlius, DA Cameron, L Dal Lago, JP Donnelly, N Kearney, ... European journal of cancer 47 (1), 8-32, 2011 | 1276 | 2011 |
| Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review L Rogers, I Barani, M Chamberlain, TJ Kaley, M McDermott, J Raizer, ... Journal of neurosurgery 122 (1), 4-23, 2015 | 723 | 2015 |
| EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and … MS Aapro, DA Cameron, R Pettengell, J Bohlius, J Crawford, M Ellis, ... European journal of cancer 42 (15), 2433-2453, 2006 | 672 | 2006 |
| Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO) R Soffietti, U Abacioglu, B Baumert, SE Combs, S Kinhult, JM Kros, ... Neuro-oncology 19 (2), 162-174, 2017 | 517 | 2017 |
| EANO guideline on the diagnosis and management of meningiomas R Goldbrunner, P Stavrinou, MD Jenkinson, F Sahm, C Mawrin, ... Neuro-oncology 23 (11), 1821-1834, 2021 | 473 | 2021 |
| ESTRO-ACROP guideline “target delineation of glioblastomas” M Niyazi, M Brada, AJ Chalmers, SE Combs, SC Erridge, A Fiorentino, ... Radiotherapy and oncology 118 (1), 35-42, 2016 | 431 | 2016 |
| Epidemiology of glial and non-glial brain tumours in Europe E Crocetti, A Trama, C Stiller, A Caldarella, R Soffietti, J Jaal, DC Weber, ... European journal of cancer 48 (10), 1532-1542, 2012 | 417 | 2012 |
| Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3 … MJ van den Bent, B Baumert, SC Erridge, MA Vogelbaum, AK Nowak, ... The Lancet 390 (10103), 1645-1653, 2017 | 398 | 2017 |
| Treatment planning and verification of proton therapy using spot scanning: initial experiences AJ Lomax, T Böhringer, A Bolsi, D Coray, F Emert, G Goitein, M Jermann, ... Medical physics 31 (11), 3150-3157, 2004 | 361 | 2004 |
| Historical benchmarks for medical therapy trials in surgery-and radiation-refractory meningioma: a RANO review T Kaley, I Barani, M Chamberlain, M McDermott, K Panageas, J Raizer, ... Neuro-oncology 16 (6), 829-840, 2014 | 273 | 2014 |
| Results of spot-scanning proton radiation therapy for chordoma and chondrosarcoma of the skull base: the Paul Scherrer Institut experience DC Weber, HP Rutz, ES Pedroni, A Bolsi, B Timmermann, J Verwey, ... International Journal of Radiation Oncology* Biology* Physics 63 (2), 401-409, 2005 | 266 | 2005 |
| Atypical and malignant meningioma: outcome and prognostic factors in 119 irradiated patients. A multicenter, retrospective study of the Rare Cancer Network D Pasquier, S Bijmolt, T Veninga, N Rezvoy, S Villa, M Krengli, DC Weber, ... International Journal of Radiation Oncology* Biology* Physics 71 (5), 1388-1393, 2008 | 263 | 2008 |
| Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus Group S Stacchiotti, A Gronchi, P Fossati, T Akiyama, C Alapetite, M Baumann, ... Annals of Oncology 28 (6), 1230-1242, 2017 | 222 | 2017 |
| The ROAM/EORTC-1308 trial: radiation versus observation following surgical resection of atypical meningioma: study protocol for a randomised controlled trial MD Jenkinson, M Javadpour, BJ Haylock, B Young, H Gillard, J Vinten, ... Trials 16, 1-8, 2015 | 220 | 2015 |
| European Organisation for Research and Treatment of Cancer. 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of … MS Aapro, J Bohlius, DA Cameron, L Dal Lago, JP Donnelly, N Kearney, ... Eur J Cancer 47 (1), 8-32, 2011 | 216 | 2011 |
| Incidence and relative survival of chordomas: the standardized mortality ratio and the impact of chordomas on a population NR Smoll, OP Gautschi, I Radovanovic, K Schaller, DC Weber Cancer 119 (11), 2029-2037, 2013 | 208 | 2013 |
| Towards FLASH proton therapy: the impact of treatment planning and machine characteristics on achievable dose rates S Van De Water, S Safai, JM Schippers, DC Weber, AJ Lomax Acta oncologica 58 (10), 1463-1469, 2019 | 193 | 2019 |
| QA makes a clinical trial stronger: evidence-based medicine in radiation therapy DC Weber, M Tomsej, C Melidis, CW Hurkmans Radiotherapy and Oncology 105 (1), 4-8, 2012 | 190 | 2012 |
| Long term outcomes of patients with skull-base low-grade chondrosarcoma and chordoma patients treated with pencil beam scanning proton therapy DC Weber, R Malyapa, F Albertini, A Bolsi, U Kliebsch, M Walser, A Pica, ... Radiotherapy and Oncology 120 (1), 169-174, 2016 | 185 | 2016 |
| Androgen deprivation and high-dose radiotherapy for oligometastatic prostate cancer patients with less than five regional and/or distant metastases U Schick, S Jorcano, P Nouet, M Rouzaud, H Vees, T Zilli, O Ratib, ... Acta oncologica 52 (8), 1622-1628, 2013 | 184 | 2013 |
